Author:
Kruger Eliza,Aggio Daniel,de Freitas Hayley,Lloyd Andrew
Funder
Ultragenyx Pharmaceutical
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference33 articles.
1. Bali DS, Chen YT, Austin S, Goldstein JL. Glycogen storage disease type I. Seattle: University of Washington; 2016.
2. Parikh NS, Ahlawat R. Glycogen Storage disease type I (Von Gierke disease). Tampa: StatPearls, StatPearls Publishing; 2019.
3. Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16(11): e1.
4. Kim YM, Choi JH, Lee BH, Kim GH, Kim KM, Yoo HW. Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia. Orphanet J Rare Dis. 2020;15(1):45.
5. Kaiser N, Gautschi M, Bosanska L, Meienberg F, Baumgartner MR, Spinas GA, et al. Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry. Mol Genet Metab. 2019;126(4):355–61.